Bupropion Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Podcasts
• Alerts
• Clinical Trials
• Forums

Axsome Therapeutics Announces Publication of Pivotal Ascend Phase 2 Trial of AXS-05 in Major Depressive Disorder in the American Journal of Psychiatry
In this study, AXS-05 (dextromethorphan-bupropion) demonstrated rapid, substantial, and statistically significant antidepressant efficacy compared with the active comparator bupropion NEW YORK, May 18, 2022 /PRNewswire/ -- Axsome Therapeutics,... (Source: Drugs.com - Clinical Trials)
Source: Drugs.com - Clinical Trials - May 18, 2022 Category: Pharmaceuticals Source Type: clinical trials

Integrating Tobacco Use Cessation Into HIV Care and Treatment in Kisumu County, Kenya
Conditions:   Tobacco Use Cessation;   Tobacco Use Interventions:   Behavioral: Tobacco Use Cessation Counselling Sessions;   Drug: Bupropion;   Drug: Nicotine patch;   Drug: Nicotine lozenge Sponsors:   University of California, San Francisco;   Kenya Medical Research Institute;   National Cancer Institute (NCI) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 28, 2022 Category: Research Source Type: clinical trials